Member Info for BeardedDragon

An English translation please, Mr Connor. Your statement makes little sense.

You are the disaster waiting to happen, Sharebel.

You complete moron, Bobrad, posting about suspended PPP on the ALRT bulletin board. What is wrong with you?

"As at 30 June 2025, the Group had cash and cash equivalents of £557,986 (30 June 2024: £528,464) and net assets of £6,676,542 (30 June 2024 £6,649,885).

Despite challenging market conditions, the Company raised £318,600 before expenses in April 2025, and £500,000 before expenses, post period end, in August 2025, demonstrating its ongoing ability to secure funding and the confidence investors have in the Company's future"...not sure that another fund raising will happen this year, maybe early next year in my view.

Absolutely no idea why your arse should be twitching. Holding gold is the safest haven in these volatile times. If you do actually hold 9.6 million shares then why does your Opinion not show more positivity?

So Warrie if you reckon that buys outnumber sells nearly 3:1 then why is the SP currently down 7%? What am I missing here?

Says who? Show us the evidence when making such wild statements. We are talking about a company which has tested on just three patients. If it was 300 then maybe you would be more credible.

Of course you agree Louise because YOU are the cross ramper!

Steve, you are the complete opposite of Sharebel, who recommends Strong Sell on all his posts.

5.0p just paid so clearly on the rise.

What are you talking about, Duster?

The conversion of the Convertible Bonds will provide a significant improvement to Renalytix's balance sheet, improving the Company's net asset position by approximately $4m and saving up to $1.4m in accrued interest over the remaining life of the loan. The conversion will also improve the Company's debt to equity ratio.

"As we mark World Mental Health Day, we are very much aware of the impact mental health conditions have on quality of life for sufferers and their families. We are on track with our work to enable our orexin-1 blocker to be used in clinical trials in under a year from now. The promise of these potential medicines is made very clear in the recent European Biopharma Review article and we look forward to reminding the industry and investors of the opportunity and plans for our lead programme during the upcoming conference season."

Guys, please don't reply on the Sharebel thread as his nonsense should not be allowed to stay in a prominent position on our screens. Let it simply slip away into obscurity. He has a mental health problem and just cannot allow punters to enjoy the fruits of their labour..

Presumably you meant to say 24 million.

Am expecting the dump to stall around 0.30p which is my new buy back target after selling at 0.47p earlier today.

Have you not seen the 40% spread at ICON? A waste of time investing there.

CR, surely you cannot believe in a company which has only managed to treat three patients? If it was 300 then I might be interested.

Personally I think the SP will more than double by Xmas. Just my gut feeling. Having just seen my GDR holding rise 100% this morning, I am fairly confident.

Have just sold half of my holding at 0.47p. Probably too soon but I cannot dare to look this gift horse in the mouth. Will buy back if/when it falls back to 0.35p.